|
Nutrition 21, Inc.
4 Manhattanville Road
Purchase, NY 10577
Phone: 914-701-4500
|
 |
 |
Patent Portfolio |
|
Nutrition 21’s proven ability to identify, develop and successfully market patented products provides a degree of competitive insulation in the marketplace, and is a competency infrequently cultivated in the nutrition industry. Its intellectual property estate is a distinguishing Company hallmark.
The Company honed its patent expertise in its early years as a biotechnology company focused on anti-microbial drug development, and then translated this expertise to the nutrition sector when it began repositioning itself in 1995 as a nutrition company.
In the past few years, the patent portfolio has contributed to the success and growth of the company in the following ways:
- Out-licensing of nisin and lysostaphin technologies
- Issued patents have helped establish and maintain a premium market for the nutritional uses of the Company’s flagship ingredient, Chromax® chromium picolinate in the human nutrition and animal feed markets
- In-licensing and purchase of patents has secured potentially promising opportunities for new chromium applications
- The competitive advantage secured through newly issued patents on new chromium-based nutrition therapies provides cost justification for the research programs required to bring these new therapies to market
- Cost-effective patent monitoring and enforcement efforts have made a significant positive contribution to bottom-line results
The Company continues to build on its existing intellectual property estate, and actively manages this asset to create added value for all of the Company’s stakeholders. |
 |
|